Literature DB >> 21757300

Evidence against GB virus C infection in dromedary camels.

Jack T Stapleton1, Donald B Smith, Peter Simmonds.   

Abstract

A recent publication described finding GB virus C (GBV-C) RNA in 4 of 22 dromedary camel sera, and sequence analysis found that these viruses were phylogenetically clustered within human GBV-C isolates. Since all other GB viruses to date form monophyletic groups according to their host species, the close relationship between the sequences generated from camel sera and human GBV-C isolates seemed implausible, leading us to conduct an independent analysis of the sequences. Our investigation found three lines of evidence arguing against GBV-C infection in dromedary camels. First, strong evidence of artifactual sequence generation was identified for some of the sequences. Secondly, the sequence diversity within individual camel sera was 10-152-fold greater than that described for GBV-C within a human host. Finally, GBV-C sequences generated from each camel shared near complete identity with human isolates previously described by the same laboratory. Taken together, these data strongly suggest laboratory contamination. We suggest that additional validation experiments are needed before it is possible to conclude that camels are permissive for GBV-C infection.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21757300      PMCID: PMC3210887          DOI: 10.1016/j.vetmic.2011.06.017

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  15 in total

1.  Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5' non-coding region.

Authors:  D B Smith; N Cuceanu; F Davidson; L M Jarvis; J L Mokili; S Hamid; C A Ludlam; P Simmonds
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

2.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

Authors:  Koichiro Tamura; Joel Dudley; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2007-05-07       Impact factor: 16.240

3.  High prevalence of GB virus C strains genetically related to strains with Asian origin in Nicaraguan hemophiliacs.

Authors:  M A González-Pérez; H Norder; A Bergström; E Lopéz; K A Visoná; L O Magnius
Journal:  J Med Virol       Date:  1997-06       Impact factor: 2.327

4.  Origin and evolution of GBV-C/hepatitis G virus and relationships with ancient human migrations.

Authors:  A Pavesi
Journal:  J Mol Evol       Date:  2001-08       Impact factor: 2.395

5.  Phylogenetic analysis of GBV-C/hepatitis G virus.

Authors:  D B Smith; M Basaras; S Frost; D Haydon; N Cuceanu; L Prescott; C Kamenka; D Millband; M A Sathar; P Simmonds
Journal:  J Gen Virol       Date:  2000-03       Impact factor: 3.891

6.  Detection and genotyping of GBV-C virus in the United Arab Emirates.

Authors:  Raed O Abu Odeh; Moslih I Al-Moslih; Mohammed Wafi Al-Jokhdar; Sinda A Ezzeddine
Journal:  J Med Virol       Date:  2005-08       Impact factor: 2.327

7.  Diversity of hepatitis G virus within a single infected individual.

Authors:  L Shao; H Shinzawa; X Zhang; D B Smith; H Watanabe; H Mitsuhashi; K Saito; T Saito; H Togashi; T Takahashi
Journal:  Virus Genes       Date:  2000-10       Impact factor: 2.332

8.  Five new or recently discovered (GBV-A) virus species are indigenous to New World monkeys and may constitute a separate genus of the Flaviviridae.

Authors:  J Bukh; C L Apgar
Journal:  Virology       Date:  1997-03-17       Impact factor: 3.616

9.  Detection in chimpanzees of a novel flavivirus related to GB virus-C/hepatitis G virus.

Authors:  N J Adams; L E Prescott; L M Jarvis; J C Lewis; M O McClure; D B Smith; P Simmonds
Journal:  J Gen Virol       Date:  1998-08       Impact factor: 3.891

10.  Identification of two flavivirus-like genomes in the GB hepatitis agent.

Authors:  J N Simons; T J Pilot-Matias; T P Leary; G J Dawson; S M Desai; G G Schlauder; A S Muerhoff; J C Erker; S L Buijk; M L Chalmers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.